Zimmer Biomet stock holds near USD 94 as analysts see upside
Published on 09/22/2026 at 13:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Zimmer Biomet Holdings, Inc. (ISIN US98956P1021) opened at USD 94.27 on the New York Stock Exchange on September 22, 2026, with a market capitalization of USD 17.98 billion. The price stood below the 52-week high of USD 106.88 and above the 52-week low of USD 79.12, leaving valuation and earnings execution as the central measures for the stock.
Analysts see measured upside
According to MarketBeat on September 22, 2026, 22 brokerages held a consensus rating of Hold, with 14 Hold ratings, six Buy ratings and two Sell ratings. Their average 12-month price target was USD 103, which is USD 8.73 above the opening price of USD 94.27.
The analyst split points to a restrained setup rather than a one-sided call. UBS maintained a Buy rating with a USD 120 target on August 6, 2026, while Robert W. Baird set a USD 104 target and Sanford C. Bernstein raised its target from USD 91 to USD 93 on the same date, according to MarketBeat.
August earnings beat estimates
Zimmer Biomet reported adjusted earnings per share of USD 2.07 and revenue of USD 2.18 billion for the quarter reported on August 5, 2026, according to MarketBeat. EPS exceeded the USD 2.01 consensus by USD 0.06, while revenue was USD 50 million above the USD 2.13 billion estimate.
Revenue increased 4.8 percent year over year in that quarter, and Zimmer Biomet kept fiscal 2026 adjusted EPS guidance at USD 8.47 to USD 8.59. The company also reported a 9.48 percent net margin for the period, giving investors a concrete measure of profitability alongside the revenue growth.
Dividend date adds a near term checkpoint
The next dated shareholder event is the September 30, 2026 ex-dividend date for a quarterly dividend of USD 0.24 per share, according to MarketBeat. The annualized dividend is USD 0.96 per share, equivalent to a stated 1.0 percent yield, while the payment date is October 30, 2026.
For investors, the comparison between the USD 2.07 quarterly EPS result and the USD 2.01 consensus is more informative than the dividend alone. The stock opened at USD 94.27 on September 22, 2026, while the average analyst target stood at USD 103 and the highest cited target reached USD 120.
Stock remains below yearly high
Zimmer Biomet stock opened at USD 94.27 on the New York Stock Exchange on September 22, 2026. The same market snapshot put the 52-week range at USD 79.12 to USD 106.88 and market capitalization at USD 17.98 billion, providing the dated market frame for the earnings and analyst comparisons above.
Zimmer Biomet stock at a glance
- Company: Zimmer Biomet Holdings, Inc.
- ISIN: US98956P1021
- Ticker: ZBH
- Trading venue: New York Stock Exchange
- Price (as of September 22, 2026): USD 94.27
- Market capitalization: USD 17.98 billion (as of September 22, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
